Mitsubishi UFJ Morgan Stanley Securities’s AbbVie ABBV Stock Holding History

Mitsubishi UFJ Morgan Stanley Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78K	Sell	310 -578	-65%	-$124K	0.24%	66
2026 Q1	$193K	Sell	888 -334	-27%	-$74.1K	0.47%	56
2025 Q4	$279K	Buy	+1,222	New	+$278K	0.44%	54
2023 Q1	–	Sell	-30	Closed	-$5K	–	16
2022 Q4	$5K	Sell	30 -30	-50%	-$4.6K	0.04%	149
2022 Q3	$8K	Hold	60	–	–	0.11%	118
2022 Q2	$9K	Hold	60	–	–	0.01%	118
2022 Q1	$10K	Buy	+60	New	+$8.72K	0.01%	116
2014 Q4	$56K	Buy	850 +370	+77%	+$23.3K	0.11%	42
2014 Q3	$28K	Hold	480	–	–	0.08%	95
2014 Q2	$27K	Buy	480 +130	+37%	+$6.82K	0.08%	98
2014 Q1	$18K	Sell	350 -350	-50%	-$17.7K	0.05%	132
2013 Q4	$37K	Hold	700	–	–	0.06%	92
2013 Q3	$31K	Buy	+700	New	+$31K	0.05%	124

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mitsubishi UFJ Morgan Stanley Securities's ABBV Position: Q2 2026 in Review

Mitsubishi UFJ Morgan Stanley Securities reduced its AbbVie (ABBV) stake by 65% in Q2 2026, selling an estimated $124K and leaving 310 shares worth $78K. The position accounts for 0.24% of the portfolio, ranked #66.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in ABBV in Q3 2013 and has held it in 13 quarters since. The position peaked at $279K in Q4 2025. 2,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mitsubishi UFJ Morgan Stanley Securities held 310 shares of AbbVie worth $78K as of Q2 2026.
Mitsubishi UFJ Morgan Stanley Securities sold 578 AbbVie shares in Q2 2026, an estimated $124K.
AbbVie made up 0.24% of Mitsubishi UFJ Morgan Stanley Securities's portfolio in Q2 2026, its #66 holding.
Mitsubishi UFJ Morgan Stanley Securities first reported a position in AbbVie in Q3 2013 and has held it in 13 quarters since.
Mitsubishi UFJ Morgan Stanley Securities's AbbVie position peaked at $279K in Q4 2025.
2,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q2 2026, filed 15 Jul 2026.